Los Angeles Capital Management’s Medifast MED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $775 | Hold |
73
| – | – | ﹤0.01% | 2309 |
|
|
2026
Q1 | $744 | Sell |
73
-30
| -29% | -$323 | ﹤0.01% | 2352 |
|
|
2025
Q4 | $1.25K | Buy |
+103
| New | +$1.23K | ﹤0.01% | 2469 |
|
|
2023
Q1 | – | Sell |
-11,016
| Closed | -$1.27M | – | 1243 |
|
|
2022
Q4 | $1.27M | Buy |
+11,016
| New | +$1.28M | 0.01% | 635 |
|
|
2022
Q3 | – | Sell |
-3,750
| Closed | -$677K | – | 1323 |
|
|
2022
Q2 | $677K | Buy |
3,750
+433
| +13% | +$77.5K | ﹤0.01% | 856 |
|
|
2022
Q1 | $566K | Hold |
3,317
| – | – | ﹤0.01% | 987 |
|
|
2021
Q4 | $695K | Sell |
3,317
-38
| -1% | -$7.86K | ﹤0.01% | 860 |
|
|
2021
Q3 | $646K | Sell |
3,355
-207
| -6% | -$50.9K | ﹤0.01% | 942 |
|
|
2021
Q2 | $1.01M | Sell |
3,562
-4,955
| -58% | -$1.34M | ﹤0.01% | 856 |
|
|
2021
Q1 | $1.8M | Sell |
8,517
-2,636
| -24% | -$631K | 0.01% | 657 |
|
|
2020
Q4 | $2.19M | Buy |
11,153
+202
| +2% | +$35.7K | 0.01% | 628 |
|
|
2020
Q3 | $1.8M | Buy |
+10,951
| New | +$1.8M | 0.01% | 599 |
|
|
2019
Q4 | – | Sell |
-18,180
| Closed | -$1.88M | – | 1312 |
|
|
2019
Q3 | $1.88M | Buy |
18,180
+4,550
| +33% | +$489K | 0.01% | 648 |
|
|
2019
Q2 | $1.75M | Sell |
13,630
-2,995
| -18% | -$416K | 0.01% | 687 |
|
|
2019
Q1 | $2.12M | Buy |
16,625
+340
| +2% | +$43.1K | 0.01% | 637 |
|
|
2018
Q4 | $2.04M | Sell |
16,285
-4,238
| -21% | -$725K | 0.01% | 552 |
|
|
2018
Q3 | $4.55M | Sell |
20,523
-1,840
| -8% | -$373K | 0.02% | 478 |
|
|
2018
Q2 | $3.58M | Sell |
22,363
-8,750
| -28% | -$1.12M | 0.02% | 551 |
|
|
2018
Q1 | $2.91M | Buy |
31,113
+3,815
| +14% | +$285K | 0.02% | 547 |
|
|
2017
Q4 | $1.91M | Buy |
27,298
+10,878
| +66% | +$722K | 0.01% | 681 |
|
|
2017
Q3 | $975K | Sell |
16,420
-2,357
| -13% | -$117K | 0.01% | 826 |
|
|
2017
Q2 | $779K | Sell |
18,777
-2,010
| -10% | -$87.4K | ﹤0.01% | 830 |
|
|
2017
Q1 | $922K | Buy |
20,787
+10,457
| +101% | +$450K | 0.01% | 744 |
|
|
2016
Q4 | $430K | Buy |
10,330
+860
| +9% | +$34.6K | ﹤0.01% | 920 |
|
|
2016
Q3 | $358K | Sell |
9,470
-150
| -2% | -$5.38K | ﹤0.01% | 1005 |
|
|
2016
Q2 | $320K | Buy |
9,620
+685
| +8% | +$22.1K | ﹤0.01% | 1031 |
|
|
2016
Q1 | $270K | Sell |
8,935
-25
| -0.3% | -$731 | ﹤0.01% | 981 |
|
|
2015
Q4 | $272K | Buy |
8,960
+1,180
| +15% | +$35.1K | ﹤0.01% | 1004 |
|
|
2015
Q3 | $209K | Sell |
7,780
-5,480
| -41% | -$160K | ﹤0.01% | 1102 |
|
|
2015
Q2 | $429K | Buy |
+13,260
| New | +$421K | ﹤0.01% | 973 |
|
Other funds holding MED
SCP
Los Angeles Capital Management's MED Position: Q2 2026 in Review
Los Angeles Capital Management held its Medifast (MED) position steady in Q2 2026 at 73 shares worth $775. The position accounts for ﹤0.01% of the portfolio, ranked #2309.
Los Angeles Capital Management first reported a position in MED in Q2 2015 and has held it in 30 quarters since. The position peaked at $4.55M in Q3 2018. 113 funds tracked by Wall St. Rank hold MED as of Q2 2026.
- Los Angeles Capital Management held 73 shares of Medifast worth $775 as of Q2 2026.
- Los Angeles Capital Management left its Medifast share count unchanged in Q2 2026.
- Medifast made up ﹤0.01% of Los Angeles Capital Management's portfolio in Q2 2026, its #2309 holding.
- Los Angeles Capital Management first reported a position in Medifast in Q2 2015 and has held it in 30 quarters since.
- Los Angeles Capital Management's Medifast position peaked at $4.55M in Q3 2018.
- 113 funds tracked by Wall St. Rank held Medifast as of Q2 2026.
Based on Los Angeles Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.